Cargando…

A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation

Introduction Type 2 diabetes (T2D) is emerging as a major global health concern. An associated condition, dyslipidemia, which acts as a significant modifiable risk factor for T2D, exhibits variations across different ethnicities and socioeconomic backgrounds. While many patients rely on metformin as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Mazhar, Saeed, Asjad, Khan, Muhammad Zarar, Javaid, Sana Z, Aslam, Farhan, Dar, Savida Ilyas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552574/ https://www.ncbi.nlm.nih.gov/pubmed/37809225 http://dx.doi.org/10.7759/cureus.44709

Ejemplares similares

Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
por: Mubashir, Muaz, et al.
Publicado: (2022)

Unresponsive Intractable Chronic Headache With Sitagliptin
por: Zaghloul, Ahmed, et al.
Publicado: (2018)

Empagliflozin Ameliorates Progression From Prediabetes to Diabetes and Improves Hepatic Lipid Metabolism: A Systematic Review
por: Hossain, Md Fahad, et al.
Publicado: (2022)

Masked Primary Hyperparathyroidism by Empagliflozin Use
por: Awada, Mariam, et al.
Publicado: (2022)

A Rare Case Report of Sitagliptin-Induced Angioedema
por: Sharma, Nava R, et al.
Publicado: (2022)

Sitagliptin-induced Pancreatitis: Chronic Use Would Not Spare You the Complication
por: Alkayali, Talal, et al.
Publicado: (2020)

Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018)

Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report
por: Zeidan, Bassem S, et al.
Publicado: (2020)

Six-Year Complete Remission of Type-1 Diabetes Mellitus in an Adult Treated With Sitagliptin
por: Benido Silva, Vânia, et al.
Publicado: (2023)

A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
por: Fernandez Felix, Daniel A, et al.
Publicado: (2022)

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit
por: Bteich, Fernand, et al.
Publicado: (2019)

Effectiveness of Empagliflozin With Vitamin D Supplementation in Peripheral Neuropathy in Type 2 Diabetic Patients
por: Mehta, Sanjana, et al.
Publicado: (2021)

Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
por: Nishida, Ai, et al.
Publicado: (2022)

MON-645 Association of Baseline Cardio-Metabolic Parameters on the Treatment Effects of Empagliflozin When Added to Metformin in Patients with T2D
por: Inzucchi, Silvio E, et al.
Publicado: (2020)

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis
por: Sharma, Manuj, et al.
Publicado: (2017)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

Metformin Use and Metformin-associated Lactic Acidosis in Intensive Care Unit Patients with Diabetes
por: Rajasurya, Venkat, et al.
Publicado: (2019)

Metformin-Induced Acute Hepatitis
por: Mian, Arooj, et al.
Publicado: (2023)

A Rare but Life-Threatening Case of Fournier’s Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin
por: Jahir, Tahmina, et al.
Publicado: (2022)

Metformin-associated Lactic Acidosis: An Unexpected Scenario
por: Asif, Samia, et al.
Publicado: (2019)

The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis
por: Aung, Myat, et al.
Publicado: (2020)

A Case of Metformin-Associated Lactic Acidosis
por: Mahmood, Rabia, et al.
Publicado: (2023)

Reactive Hypoglycemia From Metformin Immediate-Release Monotherapy Resolved by a Switch to Metformin Extended-Release: Conceptualizing Their Concentration-Time Curves
por: Akram, Ayesha
Publicado: (2021)

Metformin-Induced Lactic Acidosis: A Case Study
por: Chowdhury, Waliul, et al.
Publicado: (2018)

A Case Report on Metformin-Associated Lactic Acidosis
por: Rai, Harpreet K, et al.
Publicado: (2020)

Metformin-Associated Lactic Acidosis: A Case Report and Review
por: Ashraf, Shoaib, et al.
Publicado: (2022)

Vitamin D Deficiency and Associated Risk Factors in Muslim Housewives of Quetta, Pakistan: A Cross-Sectional Study
por: Hussain, Taimoor, et al.
Publicado: (2021)

A Case Report on Metformin-Associated Lactic Acidosis and Transient Blindness
por: Kalantri, Pooja, et al.
Publicado: (2020)

Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
por: Sahay, Rakesh Kumar, et al.
Publicado: (2020)

The Effectiveness of Metformin in Diabetes Prevention: A Systematic Review and Meta-Analysis
por: Patel, Dhara, et al.
Publicado: (2023)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

Effects of Metformin on Symptoms of Polycystic Ovarian Syndrome Among Women of Reproductive Age
por: Artani, Moiz, et al.
Publicado: (2018)

Metformin for the Improvement of Comorbid Depression Symptoms in Diabetic Patients: A Systematic Review
por: Hamal, Chandani, et al.
Publicado: (2022)

Life-Threatening Acidosis With Metformin and Dapagliflozin Combination Therapy: A Case Report
por: Gupta, Sushan, et al.
Publicado: (2023)

Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
por: Bodepudi, Ranita, et al.
Publicado: (2023)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study
por: Ahmed, Ibrar, et al.
Publicado: (2022)

Type 1 Diabetes Mellitus Management and Islet Cell Therapy: A New Chapter in Patient Care
por: Alam, Sadaf, et al.
Publicado: (2023)

SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial
por: Rosenstock, Julio, et al.
Publicado: (2019)

SAT-LB030 Efficacy of Combined Therapy with Metformin and Sitagliptin in Patients with Type 2 Diabetes Who Did Not Reach Target Levels of Glycated Hemoglobin on Metformin Monotherapy
por: Klitsunova, Yuliia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3lh74nn8aq7voh8qa4qdl4nr6r